Patient Registry Special Interest Group
Data Working Group

Analysis of Effectiveness in Patient Registry Data

The citation for this paper is:
Malmenas M, Lowton K, Morin I, et al. Analysis of Effectiveness in Patient Registry Data. ISPOR CONNECTIONS 2009; 15: 9-10.

Developed by The Data Working Group

Chair:
Maria Malmenäs MSc, Shire Human Genetic Therapies, Stockholm, Sweden and Boston, MA, USA

Leadership:
Keith Lowton MSc, Shire Human Genetic Therapies, Stockholm, Sweden and Boston, MA, USA  
Isabelle Morin MSc, Shire Human Genetic Therapies, Stockholm, Sweden and Boston, MA, USA   
Margaret Hux MSc, i3 Innovus, Burlington, ON, Canada
Lusine Abrahamyan MD, MPH, University of Toronto, Toronto, ON, Canada
Mike Novotny MBA, MA, Medrio, Oakland, CA, USA

Activities:

Analysis of Effectiveness and Cost-Effectiveness in Patient Registries
May 2009 –ISPOR 14th Annual International Meeting, Workshop Presentation, Orlando, Florida, USA


ISPOR GOOD RESEARCH PRACTICES INDEX